<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04680130</url>
  </required_header>
  <id_info>
    <org_study_id>19-009999</org_study_id>
    <nct_id>NCT04680130</nct_id>
  </id_info>
  <brief_title>Clinico-Pathologic-Genetic-Imaging Study of Neurodegenerative and Related Disorders</brief_title>
  <acronym>AND1</acronym>
  <official_title>Clinico-Pathologic-Genetic-Imaging Study of Neurodegenerative and Related Disorders</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators aim to learn more about symptoms suggestive of a neurodegenerative process.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators will recruit participants with symptoms suggestive of a neurodegenerative&#xD;
      and/or related disease. Participants could be evaluated on a yearly basis, undergoing a&#xD;
      baseline visit and possible follow-up evaluations with an interval of one year. At each&#xD;
      visit, participants could undergo any combination of the following based on their symptoms&#xD;
      and complaints: a neurological assessment, a speech/language assessment, a neuropsychometric&#xD;
      assessment, an MRI, an FDG PET/CT scan, a PiB PET/CT scan, a Tau PET/CT scan, a DaTscan, a&#xD;
      gait lab test, an ocular motor or eye movement exam and/or a swallow evaluation. At baseline&#xD;
      only, all participants will be asked to provide a blood sample to allow for future genetic&#xD;
      studies.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2020</start_date>
  <completion_date type="Anticipated">November 1, 2050</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2050</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Imaging analysis</measure>
    <time_frame>1 year</time_frame>
    <description>Longitudinal images and correlates will be measured and tracked to determine direct correlations in the brain with disease progression on a yearly basis</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>PSP</condition>
  <condition>CBD</condition>
  <condition>PCA</condition>
  <condition>LPA</condition>
  <condition>Semantic Dementia</condition>
  <condition>Semantic Aphasia</condition>
  <condition>Behavioral Variant of Frontotemporal Dementia</condition>
  <condition>FTD</condition>
  <condition>PPA</condition>
  <condition>Apraxia of Speech</condition>
  <arm_group>
    <arm_group_label>Neurodegenerative symptoms</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>C-11 PiB</intervention_name>
    <description>Completing PET scan looking for amyloid protein</description>
    <arm_group_label>Neurodegenerative symptoms</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>AV1451 Tau</intervention_name>
    <description>Completing PET scan looking for tau protein</description>
    <arm_group_label>Neurodegenerative symptoms</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Symptoms of neurodegenerative disease&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All participants will be over the age of 21&#xD;
&#xD;
          -  Have symptoms suggestive of a neurodegenerative and/or related disorder&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Participants will be excluded if they have any concurrent illnesses that could account&#xD;
             for all of their symptoms, such as traumatic brain injury, encephalitis, strokes or&#xD;
             developmental syndromes&#xD;
&#xD;
          -  Women that are pregnant or post-partum and breast-feeding will be excluded&#xD;
&#xD;
          -  Participants will be excluded if they have any of the following genetic conditions&#xD;
             which can increase the chance of cancer: Cowden disease, Lynch syndrome,&#xD;
             Hypogammaglobulinemia, Wiskott-Aldrich syndrome and Down's syndrome&#xD;
&#xD;
          -  Participants will be excluded from undergoing the MRI if it is contraindicated (metal&#xD;
             in head, cardiac pace maker, etc), if there is severe claustrophobia, if there are&#xD;
             conditions that may confound brain imaging studies (e.g. structural abnormalities,&#xD;
             including subdural hematoma, intracranial neoplasm or large cortical infarcts)&#xD;
&#xD;
          -  Participants will be excluded if they are medically unstable or are on medications&#xD;
             that might affect brain structure or metabolism (e.g. chemotherapy)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Sarah Boland, CCRP</last_name>
    <phone>507-284-3863</phone>
    <email>boland.sarah@mayo.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Boland, CCRP</last_name>
      <phone>507-284-3863</phone>
      <email>boland.sarah@mayo.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>November 3, 2020</study_first_submitted>
  <study_first_submitted_qc>December 21, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 22, 2020</study_first_posted>
  <last_update_submitted>December 21, 2020</last_update_submitted>
  <last_update_submitted_qc>December 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Keith A. Josephs</investigator_full_name>
    <investigator_title>Professor of Neurology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dementia</mesh_term>
    <mesh_term>Aphasia</mesh_term>
    <mesh_term>Frontotemporal Dementia</mesh_term>
    <mesh_term>Aphasia, Primary Progressive</mesh_term>
    <mesh_term>Pick Disease of the Brain</mesh_term>
    <mesh_term>Apraxias</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

